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Defective Interplay of Activators and Repressors
with TFIIH in Xeroderma Pigmentosum
normalities associated with cancer (Marcu et al., 1992;
Dang et al., 1999; Grandori et al., 2000). In xeroderma
pigmentosum, an inherited disorder of DNA repair, ac-
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Two complementation groups, XPB and XPD, encodeOklahoma Medical Research Foundation
subunits of transcription factor IIH (TFIIH) (Gerard et al.,825 Northeast 13th Street
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Svejstrup et al., 1996). Human holo-TFIIH is composed
of a six subunit core including 39-59 (XPB) and 59-39
(XPD) helicases, and a three subunit kinase complexSummary
(CAK: cdk7, cyclin H, and MAT1) (Akoulitchev et al. 1995;
Drapkin et al., 1996; Reardon et al., 1996; Rossignol etInherited mutations of the TFIIH helicase subunits xe-
al., 1997). Holo-TFIIH is required for transcription (Drap-roderma pigmentosum (XP) B or XPD yield overlapping
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1996; Conaway et al., 2000). Only the core participatesof cancer in these patients is not fully explained by
in DNA repair (Araujo et al., 2000). The CAK is not yetthe repair defect. The transcription defect is subtle
associated with a syndrome.and has proven more difficult to evaluate. Here, XPB
The transcriptional role of TFIIH is complex. TFIIH isand XPD mutations are shown to block transcription
recruited into preinitiation complexes (PICs) at promot-activation by the FUSE Binding Protein (FBP), a regula-
ers (Lis and Wu, 1994; Goodrich et al., 1996; Orphanidestor of c-myc expression, and repression by the FBP
et al., 1996; Roeder, 1996; Ptashne and Gann, 1997;Interacting Repressor (FIR). Through TFIIH, FBP facili-
Struhl, 1999; Green, 2000). A series of enzymatic reac-tates transcription until promoter escape, whereas
tions, structural isomerizations, and transitions of pro-
after initiation, FIR uses TFIIH to delay promoter es-
tein and nucleic acid components transform the PIC
cape. Mutations in TFIIH that impair regulation by FBP into an elongation complex that extends the nascent
and FIR affect proper regulation of c-myc expression transcript (Drapkin and Reinberg, 1994; Goodrich and
and have implications in the development of malig- Tjian, 1994; Goodrich et al., 1996; Roeder, 1996; Dvir et
nancy. al., 1997; Holstege et al., 1997; Kugel and Goodrich,
1998; Kumar et al., 1998; Moreland et al., 1999; Yan et
Introduction al., 1999; Conaway et al., 2000). This process involves
scores of polypeptides assembled into many complexes
Cancer results from accumulated mutations and chro- and subcomplexes (Orphanides et al., 1996; Roeder,
mosomal abnormalities yielding malfunctioning or im- 1996). At different promoters, distinct subsets of general
properly regulated genes. The pace of carcinogenesis transcription factors support transcription in vitro, ac-
is determined by the required number of genetic and cording to DNA topology (Parvin and Sharp, 1993; Good-
epigenetic lesions and by the rate at which these lesions rich and Tjian, 1994). At an individual promoter, each
accrue (De Pinho, 2000; Hanahan and Weinberg, 2000). round of transcription may use different subsets of fac-
Disregulated expression of c-myc, encoding a bZIP- tors and follow variant reaction pathways on successive
HLH protein, is among the most frequent molecular ab- rounds (Yudkovsky et al., 2000). For a single cycle of
the transcription, it is unknown whether PIC assembly
preprograms all the ensuing steps or whether the tran-7 To whom correspondence should be addressed (e-mail: levens@
helix.nih.gov). scription machinery responds in real time to the dynamic
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Figure 1. The Activation Domain of FBP
Makes Multiple TFIIH Contacts
(A) Purified recombinant FPBC bound to Ni1-
chelated beads mixed with 5 mg of HeLa nu-
clear extract. Purified proteins were analyzed
using antibodies against components of the
basal machinery. TFIIH subunits p62, p89,
and Cyclin H consistently copurified with
FBPC.
(B) FBP interacts with TFIIH in vivo. His-tagged
FBP was transfected into HeLa cells, purified
by Ni-NTA resin, and blotted with a-p62.
(C) FBPC directly interacts with p62. Left
panel: GSTp62 or GST was bound to glutathi-
one beads and mixed with recombinant
FBPC. FBPC was detected by a-T7 antibody.
FBPC and its degradation products copuri-
fied with GSTp62 (lane 1) but not GST (lane
2). Right panel: 2 mg of indicated proteins
were separated on SDS-PAGE gel, renatured,
and probed with 125I- FBPC. p62 and its degra-
dation fragments specifically interacted with
FBPC. As a positive control, FAR protein (35
kDa) was also recognized by FBPC.
(D) FBPC makes multiple contacts with TFIIH.
In vitro translated 35S-HA-FBPC was bound
to HA-affinity matrix and incubated with equal
counts of in vitro translated 35S-FAR, Lucifer-
ase, p62, p89, or p80 in the presence of 50
ng/ml of BSA (lanes 1, 3, 5, 7, 9) or hisFBPC
(lanes 2,4, 6, 8, 10). p62, p89, and p80 as well
as FAR copurified with HA-FBPC. Pre-
blocking with soluble recombinant FBPC
abolished the interaction.
fluctuations of the local chromatin environment or the strain due to transcription at nearby promoters. The
tyrosine-rich carboxy-terminal domain of FBP (FBPC,physiological state of the cell.
TFIIH is critical for PIC assembly, open complex for- amino acid residues 449–644 of FBP) rivals E1a and
VP16 as a transactivator when fused to the Gal4 DNAmation, and promoter escape (Dvir et al., 1997; Holstege
et al., 1997; Yan and Gralla 1997; Kugel and Goodrich, binding domain (Duncan et al., 1996). Through the TFIIH/
p89/XPB helicase, FIR (FBP Interacting Repressor) re-1998; Kumar et al., 1998; Coin et al., 1999; Guzman and
Lis, 1999; Moreland et al., 1999; Bradsher et al., 2000; presses activated but not basal transcription (Liu et al.,
2000). FIR also interacts with the central DNA bindingConaway et al., 2000; Fiedler and Timmers, 2000; Kim
et al., 2000). TFIIH interacts with a variety of activators domain of FBP; together these two opposing factors
help to regulate c-myc expression.including VP16, p53, E2F, HBx, EBNA2, and the estrogen
receptor (Xiao et al., 1994; Tong et al., 1995; Wang et In this study, we show that FBPC stimulates TFIIH
helicase activity, and via TFIIH, supports a transcription-al., 1995; Blau et al., 1996; Qadri et al., 1996; Chen et
al., 2000). Besides helping to recruit TFIIH, DNA bound ally activated state until promoter escape. This postiniti-
ation, activated state is precisely reversed by FIR. Cellsactivators could regulate TFIIH activities at various tran-
sitions in the transcription cycle. Indeed, VP16 affects from XPB and XPD patients are defective for both FBPC
activation and FIR repression, but importantly remainthe ability of RNA polymerase II to escape the promoter
(Kumar et al., 1998). responsive to other activators. Disabling the FBP/FIR/
TFIIH system in XP primes vulnerable target genes, suchThe FUSE Binding protein (FBP) activates c-myc tran-
scription through the FUSE (Far UpStream Element) (Avi- as c-myc, for misexpression in neoplasia.
gan et al., 1990; Duncan et al., 1994; He et al., 2000).
FBP binds specifically with single-stranded FUSE in vitro Results
and in vivo (Duncan et al., 1994; Bazar et al., 1995;
Michelotti et al., 1996; He et al., 2000). FUSE is predicted FBPC Interacts Directly with TFIIH Subunits
Transactivators must modify either the transcriptionalto become single stranded as the encompassing DNA
becomes progressively supercoiled. In principle, FUSE machinery or the template chromatin. The FBP carboxyl
terminus (residues 449–644) is a powerful transactivator.melting and FBP binding may be coupled with torsional
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bated with his-tagged FBPC, and the resulting com-
plexes were analyzed with a-T7 (Novagen). GSTp62 effi-
ciently pulled down FBPC and FBPC fragments whereas
GST did not (Figure 1C, left panel). This interaction was
confirmed by far Western blot analysis; electrophoreti-
cally separated, renatured his-p62 and control proteins
were probed with purified 125I-FBPC. FBPC bound to
p62, p62 degradation products, and the positive control
protein FAR (binds specifically with the FBPC activation
motif, unpublished data; Figure 1C, right panel), but not
to other proteins. Thus, FBPC interacted directly with
p62 of TFIIH.
To see if FBPC bound other TFIIH subunits, p62, p89,
and p80, as well as luciferase and FAR were translated
in vitro using 35S-methionine and tested for binding with
immobilized 35S-HA-FBPC. Both helicase subunits, p62
and FAR, but not luciferase, were recovered from the
beads (Figure 1D). Soluble, FBPC competitor blocked
p62, p89, and p80 recovery. Thus, FBP, like p53, inter-
acts with p62, p89, and p80.
FBPC Stimulates p89/XPB/ERCC3 Helicase Activity
and Promotes Transcription Initiation
TFIIH contains multiple enzymatic activities including
the p89/XPB/ERCC3 and p80/XPD/ERCC2 helicases.
The p89 39-59 helicase is obligatory for promoter melting,
initiation, and promoter escape; the p80 59-39 helicase
activity is dispensable, but stimulatory for transcription
Figure 2. FBPC Activated p89 Helicase Activity and Stimulated (Coin et al., 1999; Moreland et al., 1999; Tirode et al., 1999;
Transcription Initiation
Winkler et al., 2000). Does FBPC modify TFIIH helicase
(A) FBPC stimulated holo-TFIIH and p89-helicase activities. 10 ng activity? Although HPLC-purified hisFBPC lacked helicaseof purified human TFIIH (lanes 5–7), 40 ng of insect cell expressed
activity (Figure 2A, lanes 3 and 4), in a dose-dependentp89 (lanes 8–10), or 1 ng of SV40 T-antigen (lanes 11–13) was mixed
manner, it stimulated the TFIIH-mediated release of anwith 100 ng or 400 ng of HPLC-purified recombinant FBPC. BSA
was used to adjust the total protein. FBPC stimulated the helicase oligonucleotide annealed with single-stranded DNA
activity of holo-TFIIH and p89, but not T-antigen. FBPC alone was (Figure 2A, lanes 5–7). Purified FBPC directly activated
inactive. The relative helicase as determined by densitometry is the 39-59 helicase of purified p89/XPB (Figure 2A, lanes
indicated. 8–10). FBPC did not potentiate all helicases as SV40(B) FBPC stimulated initiation. 25 ng of recombinant G494 or G4FBPC
T-antigen was unaffected (Figure 2A, lanes 11–13). Be-was added to a transcription system reconstituted from highly puri-
cause the 39-59 helicase activity of purified, recombinantfied components and A,CTP (lanes 1 and 2) or A,C,UTP (lanes 3 and
4). G4FBPC stimulated both dinucleotide synthesis (lane 2 versus p89/XPB/ERCC3 was dramatically boosted by FBPC, it
1) and productive transcription (lane 4 versus 3). seemed that FBP should operate early in the transcrip-
tion cycle.
Does FBPC act via the essential XPB helicase early in
the transcription cycle? Reconstituted abortive initiationWhen fused with the Gal4 DNA binding, FBPC activates
and runoff transcription assays were conducted withas well as E1a or VP16. To determine whether any com-
highly purified components. Activated or basal tran-ponent(s) of the basal transcription apparatus interacts
scription was programmed by five Gal4-UAS sites up-with FBPC, purified recombinant his-tagged FBPC was
stream of AdMLP or AdMLP alone, respectively. Withbound to Ni21 chelated beads and incubated with HeLa
only ATP and CTP, G4FBPC stimulated synthesis of thenuclear extract. FBPC bound basal transcription factors
first phosphodiester bond (Figure 2B, lane 2). When UTPwere revealed by immunoblot with specific antibodies.
was also added, FBPC increased the levels of full-length,TFIIH subunits p62, p89, and Cyc H efficiently copurified
G-less transcript (Figure 2B, lane 4). FBPC-stimulatedwith hisFBPC (Figure 1A, left panel), but other basal
transcription required TFIID; TBP would not substitutefactors, TFIIB, TFIIE, TFIIF, TAFp130, and TBP, did not
(data not shown).(Figure 1A, right panel). Sometimes RNA polymerase II
was detected, but at much lower levels than TFIIH. Full-
length FBP also bound to TFIIH in vivo; Ni21 beads recov- FIR Prevents Promoter Escape, but Not
FBP-Stimulated Initiationered p62 only from extracts of hisFBPC transfected HeLa
cells, but not untransfected cells (Figure 1B). FBPC stimulated TFIIH helicase activity and increased
initiating dinucleotide synthesis. FIR, a repressor of acti-TFIIH-interacting transactivators usually bind multiple
core subunits, most often p62, p80, and p89 (Xiao et vated but not basal transcription, binds and suppresses
the TFIIH p89/XPB helicase (Liu et al., 2000). Does FIRal., 1994; Tong et al., 1995; Blau et al., 1996; Qadri et
al., 1996; Chen et al., 2000). To see if p62 bound FBPC, block FBPC-stimulated initiation or does it operate later,
to thwart TFIIH-mediated promoter escape? Althoughimmobilized, purified GSTp62 or GST alone were incu-
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Figure 3. FBPC Stimulated Both Initiation
and Promoter Escape, but FIR Expressed
Only Promoter Escape
(A) Assays used a system reconstituted from
purified factors and 10, 25, or 150 ng of re-
combinant FIR and A,CTP (lanes 1–5) or
A,C,UTP (lanes 6–10). G4FBPC (25 ng) in-
creased dinucleotide synthesis (lane 2) and
full-length transcript (lanes 7, upper band).
FIR repressed run-off transcription (lanes 8–10,
upper band), but failed to repress initiation
(lanes 3–5). Basal transcription of AdMLP was
not affected by FIR (lanes 6 through 10, lower
band).
(B) Both FBPC and FIR operate after preinitia-
tion complex formation. Left: Reconstituted
transcription reactions used immobilized tem-
plate. Lanes were loaded to normalize for the
full-length transcripts (FL). Besides stimulating
initiation (dinucleotide synthesis), G4FBPC
stimulated promoter escape by eliminating
pausing at positions 2, 3, 7, and 11 (lane 3).
G4VP16 also augmented the transition to pro-
moter escape (lane 2). Addition of 150 ng of
FIR reversed the FBPC effect on pausing
(lane 5) but still allowed initiation. FIR caused
partial pausing at 35 nucleotides. Right panel:
75 ng of affinity-purified polyclonal a-FBPC
was added either before PIC formation (lane
3) or after dinucleotide synthesis (lane 4).
a-FBPC inhibited activated transcription in
both cases. The input ratio of activated/basal
template was reduced in this experiment.
FIR did not block FBPC-stimulated dinucleotide synthe- single round, gels were loaded and normalized so that
each lane displayed the same intensity full-length tran-sis in the reconstituted transcription system (Figure 3A,
lanes 2–5), it reduced the yield of full-length products script to facilitate evaluation of the ratio of full-length/
short transcripts. Transcription reconstituted with thedown to unstimulated levels (Figure 3A, lanes 6–10).
Thus, FIR acts after initiation to holdback full-length complete set of general factors and RNA polymerase II
yielded full-length RNA and, as expected, a series oftranscript synthesis on activated, but not basal pro-
moters. incomplete transcripts (Holstege et al., 1997; Kumar et
al., 1998; Moreland et al., 1999). The incomplete prod-Dinucleotide synthesis is resistant to FIR repression,
so at what subsequent step does FIR override FBP? ucts ranged in size from two nucleotides to near full
length. No products were detected without TFIIH (dataWhy doesn’t FIR act on basal promoters? To address
these questions, transcription complexes were reconsti- not shown). Both G4FBPC and G4VP16 suppressed the
accumulation of RNA intermediates below 17 nucleo-tuted on bead-immobilized templates in the presence
or absence of chimeric Gal4 activators, with or without tides in length (Figure 3B, left, lane 1 versus lanes 2
and 3). Activators failed to suppress pausing beyond 17soluble FIR. This procedure permits the study of short
transcript synthesis by stable complexes and the exami- nucleotides, confirming that promoter escape occurred
at this position (Holstege et al., 1997; Moreland et al.,nation of products from a single transcription cycle (Ku-
mar et al., 1998). 1999). These results indicate that FBPC acts throughout
initiation and that FBPC-activated TFIIH allows more
processive transcription than basal TFIIH, which sup-FBPC Hastens Prepromoter Escape Elongation
FBPC’s postinitiation role was explored in reactions with ports only sluggish RNA synthesis.
If FBPC continues to act after PIC assembly, thenimmobilized templates. Templates bore five Gal4-UASs
upstream of AdMLP to bind recombinant Gal4 fusion interference with FBPC, post-PIC formation should de-
press activated, but not basal, RNA synthesis. Additionproteins. Because this assay limits transcription to a
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of a-FBPC to reactions programmed with basal or acti-
vated templates depressed G4FBPC activation to the
same degree whether added before or following PIC
formation under conditions allowing dinucleotide syn-
thesis (Figure 3B, right). Hence, FBPC helps to maintain
an activated state of the transcription machinery post-
PIC formation.
FIR Allows Only Basal Transcription and Delays
Promoter Escape
FIR blocks activation by FBPC, decreases p89/XPB heli-
case activity, and permits only basal transcription (Liu
et al., 2000). If FIR blunts FBP activation but not basal
transcription, then short transcripts should predominate
in immobilized template transcription reactions driven
by G4FBPC, but repressed with FIR. The distribution of
the transcripts synthesized in the presence of G4FBPC
and FIR is almost identical to the basal pattern (Figure
3B, lanes 1 and 5). Complexes yielding transcripts from 2
to 17 nucleotides were again prominent. FIR also caused
holdback at 135, a position where basal synthesis did
not pause, but where stalled complexes may still be
reactivated (Samkurashvili and Luse, 1998). TFIIH is re-
leased somewhere between 130 and 168 (Zawel et al.,
1995). FIR may encumber the TFIIH release, creating a
postpromoter escape pause. Basal TFIIH supports only
slow extension of early transcripts. FBP and VP16 put
TFIIH into a mode that efficiently transits from initiation
to elongation. FIR returns TFIIH to its ground state.
FBPC- or VP16-stimulated ejection of short RNAs
from arrested transcription complexes allowing the tran-
scription machinery to recycle is an alternate explana-
tion for the suppression of short products. With this
mechanism, activators would stimulate abortive initia-
tion, releasing soluble, short transcripts in immobilized
template assays. Such transcripts are not seen with
G4VP16 (Kumar et al., 1998).
Figure 4. FBPC Activation Is Impaired by XPB and XPD MutationsFBPC Activation Fails in XPB Cells
unless Complemented with wtTFIIHThe transcription defects due to TFIIH mutations in XP,
(A) Immortalized lymphoblast XPB cells were transfected with plas-TTD, and CS are subtle in contrast to the dramatic failure
mids expressing G4FBPC, G4VP16, or G4E1a fusion proteins andof DNA repair in these patients. How does the mutation
a CAT reporter under GAL4UAS control. Empty vector or wild-typeof a general factor, required to transcribe most, if not
XPB expression vector was also transfected. FBPC did not activate
all, genes selectively disregulate only very few targets? in XPB cells (lane 1), but VP16 and E1a did (lanes 3 and 5). FBPC
If these mutations abolished the response of the general activation was rescued by cotransfecting wild-type XPB (lane 2).
The CAT activities of the various activators 1/2XPB are graphed.factor only to specific gene regulators while preserving
(B) XPD-deficient cells are impaired, but not incapacitated for FBPCbasal transcription, then the disease phenotype would
activation. XPD fibroblasts were transfected as described in (A). Thebe defined by the specific gene targets. FIR blunts
XPD mutation decreased (lane 1), and wtXPD rescued (lane 2) FBPCFBPC-mediated TFIIH activation, but spares basal tran-
activity. VP16 and E1a were not affected by the XPD mutation (lanes
scription. FBP and FIR bind only with TFIIH and so dis- 3 to 6). CAT is graphed (right).
turbances of the FBP-FIR-TFIIH axis should not interfere (C) In vitro transcription using HeLa, XPB, and XPD nuclear extracts
yielded parallel results. G4FBPC activated transcription better thandirectly with other transcription factors operating differ-
G4VP16 in HeLa nuclear extract (lane 2 and 3), but FBPC activationently, and should not precipitate a global transcriptional
was severely impaired compared to VP16 in XPB or XPD nuclearcatastrophe. Because FBPC functions only through
extracts (lanes 5 versus 6 and 11 versus 12). The relative activity ofTFIIH, certain TFIIH mutations might selectively abro-
G4FBPC and G4VP16, and the relative stimulation upon addition of
gate FBPC activation. To test if XP patients suffer a TFIIH, were determined by denistometry. Purified rat TFIIH rescued
selective failure of the FBP-FIR system, FBPC-depen- FBPC activation (lane 8 versus 9, 14 versus 15).
(D) FBPC does not bind mutated TFIIH. As in Figure 1A, purifieddent gene activation was studied in cells and extracts
hisFBPC was bound to Ni21 beads and mixed with HeLa (5 mg), XPBdefective for p89/XPB or p80/XPD.
(25 mg), or XPD (5 mg) nuclear extract. Eluates were probed withEBV-immortalized lymphoblasts from an XPB patient
a-p62 or a-T7. Input (10%) was also loaded (Lanes 1–3). FBPCand SV40-immortalized fibroblasts from an XPD patient
copurified with wtTFIIH in HeLa (lane 4) but not mutated TFIIH from
were tested for activation of CAT reporters driven by XPB or XPD nuclear extracts (lane 5 and 6, respectively).
five Gal4-UASs upstream of a TATA-box. Plasmids ex-
Cell
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Figure 5. FBP Regulation of Endogenous
c-myc Is Impaired in XPB Fibroblasts
XPB cells were transfected with dominant
negative GFP-FBPcd in the presence or ab-
sence of wt p89 and stained for Myc. In mu-
tant cells, GFP-FBPcd failed to repress c-myc
(lower left panel). Endogenous Myc was re-
duced sharply by FBPcd and wtXPB/p89 co-
transfection.
pressing G4FBPC, G4VP16, or G4E1a were cotrans- was inactive; high levels in vitro may allow attenuated
FBPC-TFIIH activity through mass action. FBPC wasfected with wild-type p89/XPB, p80/XPD, or empty vec-
tor. Cells were harvested 48 hr posttransfection to allow also sensitive to the p80 helicase defect in XPD extracts,
whereas VP16 was insensitive (Figure 4C, lanes 11 andfor expression and incorporation of wild-type XPB or
XPD into TFIIH. Although FBPC is a potent activator in 12). These results indicate that although p80/XPD is
dispensable for basal transcription and for some activa-many cells, including HeLa, Raji, BJAB, U937, U2OS,
and Saos2 (Duncan et al., 1994; He et al., 2000), G4FBPC tors, wild-type XPD contributed to full FBPC activity.
To verify that the transcription deficit of FPBC relativefailed to activate transcription in XPB cells (Figure 4A,
lane 1). Cotransfecting wild-type XPB reconstituted to VP16 was due to defective TFIIH, nuclear extracts
were supplemented with purified TFIIH prior to in vitroFBPC transactivation (Figure 4A, lane 2). In contrast,
both G4VP16 and G4E1a were equivalently active with transcription. Wild-type TFIIH dramatically rescued
FBPC-driven transcription in reactions using XPB ex-or without complementation by wild-type XPB (Figure
4A, lanes 3 and 4, 5 and 6). The results indicate that tracts whereas VP16 activation was unchanged (Figure
4C, lanes 8 and 9 versus lanes 5 and 6). Wild-type TFIIHwild-type p89/XPB is essential for FBPC to activate tran-
scription, but not for E1a or VP16. also complemented FBPC activation in XPD extracts.
Again VP16 activation was indifferent to the p80 muta-G4FBPC activity was attenuated by the p80 mutation
in XPD cells (Figure 4B, lane 1). Cotransfection of wild- tion (Figure 4C, lanes 14 and 15 versus lanes 11 and
12). Because TFIIH is not limiting in HeLa nuclear extract,type p80/XPD augmented G4FBPC activation (Figure
4B, lane2), but not activation by G4VP16 or G4E1a (Fig- adding wild-type TFIIH had no effect on either basal or
activated transcription (Liu et al., 2000; data not shown).ure 4B, lanes 3–6). These results support the hypothesis
that the p80/XPD helicase activity assists FBPC activa- To test if the FBPC-TFIIH interaction was weakened
in XP cells, XPB, XPD, and HeLa nuclear extracts weretion, paralleling the role of p80/XPD/ERCC2 in basal
transcription. incubated with immobilized FBPC, washed, and ana-
lyzed for TFIIH coprecipitation. TFIIH was efficiently
pulled down only from HeLa cells (Figure 4D). TheseWild-Type TFIIH Rescues FBPC-Activated
results indicate that FBPC requires wild-type TFIIH sub-Transcription Using XP Nuclear Extracts
units to form a stable complex.To confirm the deficiency of FBPC activation in XPB and
XPD cells, in vitro transcription was compared between
nuclear extracts from HeLa, XPB, and XPD cells. Reac- Dominant Negative FBPcd Fails to Extinguish
c-myc in XPB Cellstions were tested with recombinant G4FBPC (50 ng) or
G4VP16 (25 ng). Template plasmids p(Gal4)5-CAT and In cells with wild-type TFIIH, a dominant negative FBP
comprised only of its nucleic acid binding central do-pD56 (lacking Gal4 sites) programmed activated and
basal transcription, respectively. Under these reaction main (FBPcd) competes with FBP for binding at FUSE
and interferes with c-myc expression (He et al., 2000).conditions, G4FBPC activated much stronger than
G4VP16 in HeLa nuclear extract (Figure 4C, lanes 2 and With its activation domain rendered impotent by XPB
mutations, FBP would become an ineffective tool to3). However, in XPB nuclear extract, FBPC activation
was severely diminished whereas VP16 was unimpaired control c-myc. Hence, FBPcd should not change myc
levels in XPB cells. Transient expression of GFP-FBPcd(Figure 4C, lanes 5 and 6). The weak FBPC activation
in XPB extracts may reflect higher concentrations of failed to reduce myc levels in telomerase-immortalized
XPB fibroblasts compared to neighboring, untrans-G4FBPC in vitro than achievable in vivo where G4FBPC
Defective Transcription Regulation via TFIIH in XP
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Figure 6. Repression by FIR Required Wild-
Type TFIIH
(A) XPB, XPD, and HeLa cells were trans-
fected with pG4E1a and a FIR expression
vector. Transiently expressed FIR repressed
G4E1a HeLa (lanes 7–9). FIR repression re-
quired higher doses in XPD cells (lanes 4–6),
whereas FIR was completely incapable of re-
pression in XPB cells (lanes 1–3).
(B) FIR failed to form a stable complex with
defective TFIIH. Upper panel: immunoprecip-
itation with monoclonal a-p89. Normal mouse
IgG was used as the control antibody. FIR
copurified with TFIIH in HeLa but not XPB
nuclear extract. Input protein was 5 mg (lane
2) and 25 mg (lane 4); (relative TFIIH levels are
as in Figure 4D). TBP did not copurify with this
antibody. Lower panel: immunoprecipitation
with affinity-purified a-FIR. a-GST was the
control (Lane 2). TFIIH copurified with FIR in
HeLa and XPD extracts (lanes 3 and 4), but
only trace TFIIH purified with FIR from XPB
nuclear extract (lane 5).
fected cells (Figure 5, bottom left). Supplying both wild- pared with HeLa or XPD.) In XPB cells, G4E1a activation
was refractory to FIR overexpression (Figure 6A, lanestype p89 and GFP-FBPcd sharply reduced cellular myc
(Figure 5, top). p89 alone had only a minimal effect on 1–3). In XPD cells, higher ratios of FIR/G4E1a were re-
quired to repress than in HeLa cells (Figure 6A, lanesmyc staining (Figure 5, bottom right). (These cells carry
a different XPB mutation than in figures 4A, 4C, and 4–6). FIR repression of G4E1a in HeLa was dose depen-
dent (Figure 6A, lanes 7–9) as shown previously (Liu et4D; thus FBP disfunction may be general in XPB.) The
response of native, human c-myc to FBP requires nor- al., 2000). These results suggest that the A-C mutation
at the 39 end of p89 coding sequence renders TFIIHmal TFIIH function. In other cells, FBP helps to maintain
myc, yet in FBPC-resistant XPB cells, c-myc is still ex- unresponsive or inaccessible to FIR. Alternatively, E1a
activates in XPB cells using only basal TFIIH (and so ispressed. Why? Might the FBPC failure be balanced by
a defect of TFIIH-mediated FIR repression (Liu et al., FIR unresponsive), but through FIR-sensitive activated
TFIIH in HeLa.2000) in these cells?
FIR Does Not Repress Activated Transcription FIR Binds Only with Wild-Type p89/XPB
The simplest explanation for the failure of FIR to repressin XPB Cells
If FBPC does not activate transcription in XP cells, does in XPB cells would be loss of binding with p89/XPB. To
test whether FIR bound with mutated p89/XPB, TFIIHFIR repress? TFIIH is targeted by FIR. In addition to
FBPC, FIR represses some, e.g., E1a, but not all, e.g., was immunoprecipitated from XPB or HeLa cell nuclear
extracts with monoclonal a-p89 and examined by immu-VP16, activators. Because FBPC activation was lost in
XPB cells, it could not be tested for FIR repression. noblot with a-FIR. FIR coimmunoprecipitated with the
wild-type p89/XPB from HeLa cells, but not with theIn contrast to G4FBPC, G4E1a activated transcription
nicely in XPB, XPD, and HeLa cells, and so G4E1a was mutated p89/XPB (Figure 6B, top panel). p89 from XPB
cells was barely detectable in reciprocal immunoprecipi-used to test if FIR represses activated transcription in
XP cells. (The lower level of CAT activity in XPB cells tations using a-FIR and immunoblots with a-p89; but
wild-type p89 was abundant in immunoprecipitates fromparallels a lower percentage of transfected cells com-
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HeLa or XPD cell nuclear extracts (Figure 6B, bottom chastic fluctuations of transcript synthesis. Holding
back or releasing RNA polymerase with FBP and FIRpanel). FIR does not repress transcription in XPB cells
because it does not engage TFIIH. might have several regulatory consequences. First, syn-
thesis of the particular nascent transcript sprouting from
the regulator-engaged RNA polymerase is directly influ-Discussion
enced. Second, prolonged holdback prior to promoter
escape makes the promoter inaccessible for PIC forma-The Role of TFIIH in Specific Gene Regulation
tion even if driven by powerful factors. Third, factors andThis work shows that TFIIH is regulated throughout the
processes sensitive to the transcriptionally generatedearly stages of transcription during the transition from
torsional strain would be coupled with translocation ofinitiation to promoter escape. Specific activators and
the transcription complex. For a gene such as c-myc,repressors modulate TFIIH’s helicase activity to control
the dynamic interplay between holdback or release oftranscript extension during this transition. Mutations
polymerases (Bentley and Groudine, 1986; Strobl andthat disable this mechanism impair proper control of
Eick, 1992; Albert et al., 1997) through the action ofactivator- and repressor-specific target genes.
activators and repressors on TFIIH may confer moreTo initiate transcription, RNA polymerases must find
robust and sensitive control than is otherwise achiev-promoters, separate DNA strands, begin RNA synthesis,
able. FIR augments FBP binding to the FUSE of activeand move down the template. This process is especially
c-myc genes both in vitro (Liu et al., 2000) and in vivocomplicated for metazoan genes transcribed by RNA
(unpublished data). The interplay of FBP/FIR/TFIIH com-polymerase II. This complexity may reflect an evolution-
plex with the unwinding of FUSE due to the torsionalary pathway that simply worked well enough; on the
strain of transcription (or even due to direct helicaseother hand, the intricacy may have been selected for
action) may help to determine whether or nor a pausedprecise performance in response to physiological or
polymerase is released. Without tight control of c-myc,pathological stresses. In the first case, activators and
the pathologic consequences of disturbances in otherrepressors drive PIC assembly and the ensuing tran-
pathways, such as NER in XPB, may be amplified.scription follows a linear, stereotyped pathway (Ptashne
and Gann, 1997). In the second case, the reaction path-
way is plastic; helix opening, nucleotide addition, and Implications of Impaired TFIIH-Mediated Specific
Gene Regulation in Xeroderma Pigmentosumtranslocation are influenced throughout early transcrip-
tion by repressors and activators. Sequential nucleotide Mutation of TFIIH may have variable consequences. The
selective impairment of a general factor to perform aaddition would be governed by specific gene regulators
(Kumar et al., 1998). In fact, FBPC does alter the reaction specific adjustment in early transcription might have
limited and subtle consequences in contrast to thepathway. If FBPC merely increased the likelihood of
initiation, then the relative distribution of early tran- global transcriptional catastrophe expected from com-
plete factor failure. In mice, the complete loss of TFIIHscripts would be the same under activated and basal
conditions. FBPC binds with TFIIH, increases p89/XPB/ is lethal in two-cell embryos (de Boer et al., 1998) indicat-
ing an essential role in transcription. But some TFIIHERCC3 helicase activity, and hastens the transit of the
transcription machinery through the early stages of RNA mutants behave as if the regulation of only selected
genes were impaired. Even a slight disturbance of c-mycsynthesis. Interference with FBPC, even after PIC forma-
tion, reduces activated transcription. So the activated expression directly influences the size and growth rate
of cells in culture and tumors in vivo. Over- or underex-state of the transcription apparatus must be maintained
after recruitment. Thus, FBPC changes the PIC from a pression of c-myc can enhance or diminish, respec-
tively, p53-dependent apoptosis. p53-mediated apopto-slow-starting (local) to a fast-starting (express) initiation
to escape (IE) transition complex. Whereas unactivated sis is defective in XPB and XPD mutant cells (Wang
et al., 1996). A complicated molecular dialogue is heldtranscription complexes pause frequently prior to pro-
moter escape, FBPC-stimulated express complexes between c-myc and mutant or wild-type p53. p53 muta-
tions that activate c-myc to increase cell growth andmaking few if any stops following initiation. VP16 simi-
larly drives the transformation from local to express IE diminish apoptosis could be especially dangerous in
XPB and XPD when coupled with the impaired FBP/FIR/transition complexes (Kumar et al., 1998). Perhaps what
makes VP16 such a potent activator is its ability both TFIIH system (Frazier et al., 1998).
Disregulated c-myc may poise the cells of XP patientsto support recruitment and to activate TFIIH (Blau et al.,
1996). Thus TFIIH activation would comprise the rate- to receive a neoplastic insult. XP patients in general
suffer a thousand-fold increased risk of cutaneous ma-limiting step inferred previously (Krumm et al., 1995;
Kugel and Goodrich, 1998). VP16 must stabilize acti- lignancy. Defective nucleotide excision repair undoubt-
edly provides much, if not most, of this carcinogenicvated TFIIH because FIR is unable to block VP16-medi-
ated promoter escape (Liu et al., 2000). impulse. Yet patients with TTD and CS are spared the
most lethal consequence of accumulated mutations,Natural promoters with densely nested and heavily
occupied cis-elements may control the transition from cancer. Not only is the risk of malignancy increased
in XP, but the kinetics of tumorgenesis are drasticallyinitiation to promoter escape. Why regulate transcription
after recruitment? For genes receiving multiple activa- altered. If XP tumors arise from an acceleration of the
same multistep carcinogenesis causing skin tumors intion signals and requiring tight regulation, recruitment
alone may be too coarse for tight control. Gating the the general population, then the cumulative percentage
of patients with tumors as a function of age should yieldholdback or release of paused polymerases with spe-
cific activators and repressors may help to dampen sto- similarly shaped curves for both groups, but on different
Defective Transcription Regulation via TFIIH in XP
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(hisFBPC or his-p62), or a-GST (GSTp62). a-T7 or a-GST reactivetime scales. XP tumors accrue from infancy, tracing a
bands constituted over 95% of total protein on Coomassie stain.roughly hyperbolic curve, whereas in the general popu-
lation, squamous cell and basal cell carcinomas accu-
Protein–Protein Interaction Assays
mulate as a sigmoidal function of age, with a latent The indicated amount of nuclear extract was mixed with Ni21-che-
period of several decades (Kraemer, 1997). The differ- lated Sepharose 4B beads saturated with affinity-purified hisFBPC
ence in these curves strongly argues that inherited XP and incubated overnight at 48C in buffer BC100 with 20 mM imid-
azole. The beads were washed four times with 20 mM HEPES, pHimposes antecedent risk operating even prior to DNA
7.9, 300 mM NaCl, 0.05% Triton X-100, 50 mM imidazole and eluteddamage in XP. In cases of XPB and XPD, ineffective
with 20 mM HEPES, pH 7.9, 50 mM NaCl, 250 mM imidazole. Theinteractions between TFIIH and the products of viral
eluates were subjected to Western blot. For immunoprecipitation
and cellular oncogenes, tumor suppressor genes, or assays, affinity-purified polyclonal a-FIR or monoclonal a-p89 anti-
transcriptional regulators such as FBP and FIR may ex- body (Austral Biologicals; LeRoy et al., 1998) was crosslinked to
plain this risk. protein-A agarose beads and mixed with indicated amount of nu-
clear extracts overnight at 48C. The beads were washed four times
with 20 mM HEPES, pH 7.9, 350 mM NaCl, 0.05% Triton X-100 andExperimental Procedures
subjected to immunoblot. For immunoprecipitation of 35S-protein,
2 ml of 35S-methionione-labeled, in vitro translated HA-FBPC wasPlasmid Constructs
incubated with 0.4 ml preblocked HA-affinity matrix (Roche) for 4Reporter plasmids p(Gal4)5-CAT and pD56, activators pG4FBPC,
hr. Equal counts of 35S-methionione-labeled, in vitro translated FAR,pG4E1a, and pG4VP16, bacterial expression vectors pET28a/G494,
Luciferase, p62, p89, and p80 were incubated with 50 ng/ml of BSApET28a/G4FBPC, and pET28a/G4VP16 were described (Liu et al.,
or recombinant hisFBPC in 20 mM HEPES, pH 7.9, 300 mM NaCl,2000). FBPC (amino acid residues 449 to 644 of FBP) was cloned
0.05% Triton X-100, 0.5 mM PMSF, and 0.5 mM DTT for 4 hr. Theinto pET28a for expression. cDNA of p62 was cloned into pET28a
preblocked proteins were incubated with HA-FBPC bound resin foror pGEX-4T-1 for expression and purification. FBPC, p89, p80, and
2 hr and washed four times with the same buffer and analyzed.FAR cDNAs were HA-tagged and cloned into pcDNA3 for in vitro
translation. GBP-FBPcd and p89 expression clones were described
(He et al., 2000; Liu et al., 2000). Nuclear Extract and Purified Components
HeLa, XPD, or XPB nuclear extracts were prepared as described
(Ge et al., 1996). GTFs were purified as described (Conaway et al.,Helicase Assay
1996; Kumar et al., 1998).Helicase assays were performed as described (Liu et al., 2000). The
final concentration of bovine serum albumin was increased to 0.24
mg/ml. 10 ng of affinity-purified human TFIIH (Le Roy et al., 1998), In Vitro Transcription
40 ng of insect cell expressed p89, or 1 ng of SV40 T-antigen was In vitro transcription with nuclear extract was conducted as de-
added to together with BSA and 100 ng or 400 ng of HPLC-purified scribed (Liu et al., 2000). Purified rat TFIIH (Conaway et al., 1996)
hisFBPC. was incubated with XPB or XPD nuclear extracts to rescue transcrip-
tion. For antibody inhibition, 75 ng of affinity-purified polyclonal
a-FBPC was added either prior to or after ApC dinucleotide for-Far-Western Blot
mation.2 mg of GST, his-FIR, p62, FBPC, or FAR was separated by SDS-
Reconstituted transcription with soluble templates was describedPAGE, transferred to nitrocellulose, and renatured for 4 hr with three
(Kumar et al., 1998) except PC4 was added to all reactions. G-lesschanges of 0.5% Triton X-100 in PBS. The membrane was blocked
cassette driven by pG5AdML or pAdML represents activated orwith 2.5% nonfat dry milk and 10 mg/ml BSA in PBS. 3 3 106 dpm/
basal transcription. Preinitiation complex was assembled with highlyml 125I-hisFBPC (Lofstrand Labs) in PBS with 0.5% milk, 5 mg/ml
purified TFIIH (LeRoy et al., 1998), RNAPII, and GTFs together withBSA, 0.5 mM DTT, 1 mM PMSF was incubated with the membrane
25 ng of G4FBPC or G494.for 16 hr at 48C. The blot was washed four times with 20 mM sodium
In vitro transcription assays used immobilized pG5U50 DNA as thephosphate, pH 7.4, 250 mM NaCl, 0.1% NP-40 and subjected to
template directing transcription of a 50-nucleotide U-less cassetteautoradiography.
driven by five Gal4 binding sites upstream of the AdMLP (Zawel et
al., 1995; Kumar et al., 1998). Preinitiation complexes were assem-Cell Culture and Transfection
bled on the immobilized DNA template by incubating 4-fold excessEBV-immortalized XPB lymphocytes (GM02252C, XP11BE) were cul-
of GTFs and RNAPII, washed, and processed.tured in RPMI-1640 with 15% FBS. HeLa and SV40-immortalized
XPD fibroblasts (GM08297, XP6BE (SV40), R683W) were cultured in
ImmunofluorescenceDulbeco’s modified Eagle’s medium with 10% FBS. XPB cells were
Telomerase-immortalized XPB fibroblasts (GM13026, XPCS2BA,transfected with Lipofectamine 2000 reagent (LTI). pG4FBPC (200
F99S) were transfected with 1 mg of pEGFP or pEGFP/FBPcd andng), pG4E1a (50 ng), or pG4VP16 (25 ng) expression vectors were
with 2 mg p89 expression vector or empty vector as control usingcotransfected with 2 mg of wild-type XPB expression vector or
FuGENE (Roche). Immunostaining was performed 20 hr post-trans-empty vector. XPD cells were transfected by Lipofactamine Plus
fection as described (He et al., 2000). c-Myc was stained with poly-(LTI) with pG4FBPC (25 ng), pG4E1a (10 ng), and pG4VP16 (2 ng).
clonal a-c-Myc antibody (Upstate) diluted 1:100 in blocking solution2 mg of XPD expression vector or empty vector was also transfected.
and then detected with TRITC-conjugated anti-rabbit antiserumFor FIR repression assays, pG4E1a (50 ng for XPB cells, 10 ng for
(Sigma).XPD and HeLa) was transfected along with FIR (0, 200, and 1000
ng for XPB cells; 0, 40, and 200 ng for XPD and HeLa). 500 ng of
reporter p(Gal4)5-CAT was cotransfected in all transfections. Cells Acknowledgments
were harvested 48 hr post-transfection and assayed for CAT activity.
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